Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade. - Samson A; Scott KJ; Taggart D; West EJ; Wilson E; Nuovo GJ; Thomson S; Corns R; Mathew RK; Fuller MJ; Kottke TJ; Thompson JM; et al. (Science translational medicine, 2018)